Inventor
FASCHING BERNHARD
CH16 patents
⚠️ This page may combine multiple inventors who share the name “FASCHING BERNHARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
10 patentsUS11098080B2Aug 24, 2021
Peptide macrocycles against Acinetobacter baumannii
HOFFMANN LA ROCHE3 citations71
US11066443B2Jul 20, 2021
Anti-bacterial peptide macrocycles and use thereof
HOFFMANN LA ROCHE3 citations71
US10030047B2Jul 24, 2018
Peptide macrocycles against acinetobacter baumannii
HOFFMANN LA ROCHE2 citations71
US12162887B2Dec 10, 2024
Spiro-oxazolones
HOFFMANN LA ROCHE0 citations61
US11578077B2Feb 14, 2023
Spiro-oxazolones
HOFFMANN LA ROCHE0 citations61
US12012466B2Jun 18, 2024
Peptide macrocycles against Acinetobacter baumannii
HOFFMANN LA ROCHE0 citations60
US11091471B2Aug 17, 2021
Isoxazolyl ether derivatives as GABAA α5 PAM
HOFFMANN LA ROCHE0 citations51
US10479796B2Nov 19, 2019
Spiro-oxazolones
HOFFMANN LA ROCHE0 citations51
US10092551B2Oct 9, 2018
Spiro-thiazolones
HOFFMANN LA ROCHE0 citations40
US9828385B2Nov 28, 2017
Spiro-oxazolones
HOFFMANN LA ROCHE0 citations40
ENDOGENA THERAPEUTICS INC
3 patentsUS12195452B2Jan 14, 2025
N-(4-(oxazol-5-yl)phenyl) chromane-3-carboxamide derivatives and related compounds as stimulators of the production of retinal precursor cells for the treatment of neuroretinal diseases
ENDOGENA THERAPEUTICS INC0 citations57
US10807973B2Oct 20, 2020
Compounds for use as therapeutically active substances in the treatment of retinal diseases
ENDOGENA THERAPEUTICS INC1 citations56
US10752593B2Aug 25, 2020
Compounds for use as therapeutically active substances in the treatment of retinal diseases
ENDOGENA THERAPEUTICS INC1 citations56